Craniomaxillofacial Devices Market Size Global Gathering and Future Outlook 2020 to 2027
The increasing participation of key players is one of the
key factors driving the craniomaxillofacial devices market. In 2019, Kelyniam
Global (KLYG) received premarket FDA approval for unique modifications to their
PEEK cranio-maxillofacial implant product line.Various other factors such as
the acceptance of craniomaxillofacial (CMF) devices in ambulatory settings,
increasing geriatric population, untapped emerging markets, rise in regulatory
approvals, and growing demand for bioresorbable devices are also expected to
propel the growth of the market.
The Global Craniomaxillofacial
Devices Market is expected to grow significantly over the forecast period.
It is anticipated that the market held a valuation of USD 2422 million in 2018
and is projected to register a CAGR of 7.2% over the forecast period.However,
the low success rate of surgical procedures and high costs and shortcomings of
titanium implants can hamper market growth over the forecast period.
Request
Free Sample Copy at: https://www.marketresearchfuture.com/sample_request/8011
Key Players
Some of the key players in the global CMF devices market are
Aesculap Implant System LLP, Johnson & Johnson, Kanghui Orthopedic,
OsteoMed, KLS Martin, MATRIX SURGICAL USA, Integra Lifesciences Corporation,
Medtronic, Medartis AG, Stryker, Corporation, TMJ Concepts, W.L. Gore and
Associates, Zimmer Biomet Inc., and others.
Segmentation
The global craniomaxillofacial devices market is segmented
based on product, material, application, end user, and region.
The global market for craniomaxillofacial (CMF) devices, by
product, is segmented into cranial flap fixation, craniomaxillofacial fixation
(CMF) distraction, temporomandibular joint replacement
thoracic fixation, bone graft substitute, CMF plate, and
screw fixation, and dural repair. The dural repair segment is further
classified as dural sealants and dural substitutes.
Based on material, the market is segmented into metals and
alloys, bioabsorbable, ceramics, polymers, and others.
Based on application, the market is segmented into
neurosurgery, ENT, orthognathic & dental surgery, plastic surgery, and
others.
Based on end user, the market is segmented into hospitals,
ambulatory surgical centers, and others.
The ambulatory surgical centers segment is expected to
witness the fastest growth over the forecast period due to rising acceptance of
craniomaxillofacial (CMF) devices in ambulatory settings.
Regional Analysis
In the current scope of the study, the segments mentioned
above are covered into the four global regions, namely, the Americas, Europe,
Asia-Pacific, and the Middle East and African region.
The CMF devices market in the Americas has further been
segmented into North America and South America, with the North American market
divided into the US and Canada.
The European CMF devices market has been segmented into
Western Europe and Eastern Europe. Western Europe has been classified as
Germany, France, the UK, Italy, Spain, and the rest of Western Europe. The CMF devices market in Asia-Pacific has
been segmented into Japan, China, India, South Korea, Australia, and the rest
of Asia-Pacific. The Craniomaxillofacial (CMF) Devices market in the Middle
East & Africa has been segmented into the Middle East and Africa.
Browse Detailed TOC
with COVID-19 Impact Analysis at: https://www.marketresearchfuture.com/reports/craniomaxillofacial-devices-market-8011
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to
unravel the complexity of various industries through our Cooked Research Report
(CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR
team have supreme objective to provide the optimum quality market research and
intelligence services to our clients.
Contact:
Akash Anand
Market Research Future
+1 646 845 9312
Comments
Post a Comment